Also: Delayed whooping cough diagnoses; BMJ criticizes Avandia; beliefs about stents.
See more here:
A.M. Vitals: Looking to Progeria for Clues to Heart Disease
One of every five kids and 9 of 10 older Americans took at least one prescription drug in the previous month, says a survey taken in 2008.
Go here to see the original:
Almost Half of Americans Took a Prescription Drug in Past Month
Also: NEJM editors say Meridia should be yanked; stem cell plaintiffs explain themselves to the WSJ; are hospital profits the driver of health-care costs?
Read the original here:
A.M. Vitals: Allergan Will Settle Off-Label Botox Allegations
Also: Price hike for last-resort insurance in California; potential warfarin replacements line up; dialysis deal reached in Atlanta; U.S. asks judge to allow embryonic stem cell research to proceed.
Continue reading here:
A.M. Vitals: Genzyme Says Sanofi Needs to Cough Up More Cash
About 60 million Americans have medical conditions that should be known in an emergency, but only a fraction wear medical ID or carry their health information.
Read the original here:
Boosting the Use of Medical Alert Bling To Save Lives
Also: Most C-sections performed before labor starts; American companies push into Chinese electronic medical record market; investigators looking at health-care credit cards.
Read this article:
A.M. Vitals: Genzyme Points to MS Drug As Sign Sanofi Bid is Too Low
Also: 50 million Americans on Medicaid; two studies boost Plavix rivals; pediatricians say no erectile dysfunction drug ads before 10pm.
See original here:
A.M. Vitals: Genzyme Rejects Takeover Offer From Sanofi-Aventis
Also: campaign donations by health insurers; Roche doesn’t get an accelerated review of new breast-cancer drug; Obama administration touts Medicare anti-fraud efforts.
See the article here:
A.M. Vitals: Latest J&J Recall Involves Two DePuy Hip Implants
eMarketer estimates online spending by U.S. health-care and pharma companies will hit $1.52 billion in 2014.
See the original post:
Report: Pharma Digital Spending Growing — But Slowly
Also: experimental melanoma drug results; California insurance news; radiation at Walter Reed.
See the article here:
A.M. Vitals: Judge Won’t Nix Generic Version of Sanofi’s Lovenox
